TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ALEC

Alector Inc

Healthcare · Biotechnology

1.90$ -5.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Alector Inc (ALEC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 203 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALEC
Line item Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
54 – – – 236 275 275 319 308 496 477 450 422 619 572 532 488 440 397 854 815 954 890 837 788 748 709 672 622 635 571 516 468 408 356 335 293 240 203
– – – – 233 32 270 313 293 442 415 385 357 556 510 470 422 375 329 788 750 891 827 775 726 686 648 613 566 581 520 469 425 367 319 300 266 215 180
51 – – – 32 -32 49 42 65 61 69 87 90 161 93 85 50 111 126 517 329 455 172 184 154 196 132 102 75 73 48 37 33 38 45 77 66 77 60
– – – – 32 32 268 309 290 437 411 381 353 549 504 462 413 363 320 778 735 869 809 758 713 669 630 589 549 562 503 457 413 355 307 291 256 207 173
– – – – 200 – – – – – – – – 1.5 1.4 1.2 – – – 1.6 7.4 13 8.8 6.5 2.6 4.7 7.8 10 – – – – – – – – – – –
– – – – 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
2.5 – – – 2.8 3.2 3.2 3.6 11 52 61 63 62 61 59 31 30 29 60 28 27 26 55 55 53 25 51 – – – – – – – – – – – –
1.5 – – – 288 197 37 401 406 230 232 231 227 227 217 221 221 213 213 518 514 687 601 584 573 565 512 510 488 457 420 397 342 314 285 278 263 230 213
1.5 – – – 27 37 37 41 13 56 67 59 62 72 66 71 68 64 74 133 140 143 149 161 94 99 132 155 178 165 148 143 125 110 84 80 70 41 34
– – – – – – – – 35 4.4 5.1 6.0 6.6 6.6 6.7 6.7 7.5 7.7 7.8 7.8 7.8 7.9 7.9 8.0 8.1 8.1 8.2 8.4 8.5 8.5 8.6 8.7 8.8 8.8 8.9 9.0 9.4 11 19
1.2 – – – 1.1 0.1 0.1 0.3 0.1 1.2 0.5 0.3 0.3 4.0 4.8 1.4 3.0 5.3 12 2.3 4.7 6.8 4.6 4.5 4.2 3.1 4.7 4.7 3.8 4.6 4.4 5.0 2.2 2.3 2.2 4.8 1.7 1.4 2.3
– – – – – – – – – 43 – – – – – – – – – – – – – – – – – – – – – – 9.4 9.5 9.5 9.6 9.3 8.3 –
53 – – – -52 25 78 -83 -97 266 246 219 195 392 355 310 268 228 185 336 301 268 289 253 214 183 196 163 134 179 151 119 127 95 71 58 31 10 -10.0
– – – – -62 -82 -82 -97 -114 -133 -158 -189 -220 -260 -305 -358 -410 -462 -517 -391 -446 -491 -481 -527 -580 -626 -624 -669 -710 -746 -785 -827 -829 -870 -900 -935 -972 -995 -1,018
– 8.5 8.5 30 51 51 51 51 68 68 67 68 68 75 78 79 79 79 80 85 82 82 83 83 83 83 84 84 84 94 97 97 98 99 100 103 103 111 111

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?